nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—Isoprenaline—MAPK1—ovarian cancer	0.0113	0.568	CrCbGaD
Labetalol—Ketoprofen—CXCL8—ovarian cancer	0.00428	0.214	CrCbGaD
Labetalol—Mirabegron—ABCB1—ovarian cancer	0.00301	0.151	CrCbGaD
Labetalol—Flushing—Paclitaxel—ovarian cancer	0.0021	0.00214	CcSEcCtD
Labetalol—Jaundice—Docetaxel—ovarian cancer	0.00208	0.00212	CcSEcCtD
Labetalol—Fatigue—Vinorelbine—ovarian cancer	0.00206	0.0021	CcSEcCtD
Labetalol—Hypersensitivity—Topotecan—ovarian cancer	0.00206	0.0021	CcSEcCtD
Labetalol—Constipation—Vinorelbine—ovarian cancer	0.00204	0.00208	CcSEcCtD
Labetalol—Pain—Vinorelbine—ovarian cancer	0.00204	0.00208	CcSEcCtD
Labetalol—Hypersensitivity—Melphalan—ovarian cancer	0.00201	0.00206	CcSEcCtD
Labetalol—Epistaxis—Docetaxel—ovarian cancer	0.00201	0.00206	CcSEcCtD
Labetalol—Asthenia—Topotecan—ovarian cancer	0.002	0.00204	CcSEcCtD
Labetalol—Alopecia—Paclitaxel—ovarian cancer	0.002	0.00204	CcSEcCtD
Labetalol—Vomiting—Chlorambucil—ovarian cancer	0.00199	0.00204	CcSEcCtD
Labetalol—Agranulocytosis—Docetaxel—ovarian cancer	0.00199	0.00203	CcSEcCtD
Labetalol—Mental disorder—Paclitaxel—ovarian cancer	0.00198	0.00202	CcSEcCtD
Labetalol—Pruritus—Topotecan—ovarian cancer	0.00198	0.00202	CcSEcCtD
Labetalol—Erythema—Paclitaxel—ovarian cancer	0.00197	0.00201	CcSEcCtD
Labetalol—Feeling abnormal—Vinorelbine—ovarian cancer	0.00197	0.00201	CcSEcCtD
Labetalol—Asthenia—Melphalan—ovarian cancer	0.00196	0.002	CcSEcCtD
Labetalol—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00195	0.00199	CcSEcCtD
Labetalol—Pruritus—Melphalan—ovarian cancer	0.00193	0.00197	CcSEcCtD
Labetalol—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00193	0.00197	CcSEcCtD
Labetalol—Hepatitis—Docetaxel—ovarian cancer	0.00192	0.00196	CcSEcCtD
Labetalol—Hypoglycaemia—Epirubicin—ovarian cancer	0.00192	0.00195	CcSEcCtD
Labetalol—Cardiac failure—Epirubicin—ovarian cancer	0.00192	0.00195	CcSEcCtD
Labetalol—Diarrhoea—Topotecan—ovarian cancer	0.00191	0.00195	CcSEcCtD
Labetalol—Hypoaesthesia—Docetaxel—ovarian cancer	0.00191	0.00195	CcSEcCtD
Labetalol—Lethargy—Epirubicin—ovarian cancer	0.00191	0.00195	CcSEcCtD
Labetalol—Urticaria—Vinorelbine—ovarian cancer	0.0019	0.00194	CcSEcCtD
Labetalol—Muscle spasms—Paclitaxel—ovarian cancer	0.00189	0.00193	CcSEcCtD
Labetalol—Abdominal pain—Vinorelbine—ovarian cancer	0.00189	0.00193	CcSEcCtD
Labetalol—Body temperature increased—Vinorelbine—ovarian cancer	0.00189	0.00193	CcSEcCtD
Labetalol—Oedema peripheral—Docetaxel—ovarian cancer	0.00189	0.00193	CcSEcCtD
Labetalol—Diarrhoea—Melphalan—ovarian cancer	0.00187	0.00191	CcSEcCtD
Labetalol—Nausea—Chlorambucil—ovarian cancer	0.00186	0.0019	CcSEcCtD
Labetalol—Vision blurred—Paclitaxel—ovarian cancer	0.00186	0.00189	CcSEcCtD
Labetalol—Visual impairment—Docetaxel—ovarian cancer	0.00185	0.00189	CcSEcCtD
Labetalol—Dizziness—Topotecan—ovarian cancer	0.00185	0.00188	CcSEcCtD
Labetalol—Tremor—Paclitaxel—ovarian cancer	0.00184	0.00188	CcSEcCtD
Labetalol—Affect lability—Epirubicin—ovarian cancer	0.00184	0.00188	CcSEcCtD
Labetalol—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00183	0.00186	CcSEcCtD
Labetalol—Angioedema—Paclitaxel—ovarian cancer	0.0018	0.00184	CcSEcCtD
Labetalol—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00179	0.00182	CcSEcCtD
Labetalol—Flushing—Docetaxel—ovarian cancer	0.00178	0.00182	CcSEcCtD
Labetalol—Vomiting—Topotecan—ovarian cancer	0.00178	0.00181	CcSEcCtD
Labetalol—Malaise—Paclitaxel—ovarian cancer	0.00178	0.00181	CcSEcCtD
Labetalol—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00177	0.00181	CcSEcCtD
Labetalol—Cardiac failure—Doxorubicin—ovarian cancer	0.00177	0.00181	CcSEcCtD
Labetalol—Mood swings—Epirubicin—ovarian cancer	0.00177	0.00181	CcSEcCtD
Labetalol—Vertigo—Paclitaxel—ovarian cancer	0.00177	0.0018	CcSEcCtD
Labetalol—Syncope—Paclitaxel—ovarian cancer	0.00177	0.0018	CcSEcCtD
Labetalol—Lethargy—Doxorubicin—ovarian cancer	0.00176	0.0018	CcSEcCtD
Labetalol—Rash—Topotecan—ovarian cancer	0.00176	0.0018	CcSEcCtD
Labetalol—Hypersensitivity—Vinorelbine—ovarian cancer	0.00176	0.0018	CcSEcCtD
Labetalol—Dermatitis—Topotecan—ovarian cancer	0.00176	0.0018	CcSEcCtD
Labetalol—Headache—Topotecan—ovarian cancer	0.00175	0.00179	CcSEcCtD
Labetalol—Palpitations—Paclitaxel—ovarian cancer	0.00174	0.00178	CcSEcCtD
Labetalol—Vomiting—Melphalan—ovarian cancer	0.00174	0.00177	CcSEcCtD
Labetalol—Loss of consciousness—Paclitaxel—ovarian cancer	0.00173	0.00177	CcSEcCtD
Labetalol—Liver function test abnormal—Epirubicin—ovarian cancer	0.00173	0.00176	CcSEcCtD
Labetalol—Rash—Melphalan—ovarian cancer	0.00172	0.00176	CcSEcCtD
Labetalol—Dermatitis—Melphalan—ovarian cancer	0.00172	0.00176	CcSEcCtD
Labetalol—Asthenia—Vinorelbine—ovarian cancer	0.00171	0.00175	CcSEcCtD
Labetalol—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00171	0.00174	CcSEcCtD
Labetalol—Abdominal pain upper—Epirubicin—ovarian cancer	0.00171	0.00174	CcSEcCtD
Labetalol—Affect lability—Doxorubicin—ovarian cancer	0.0017	0.00174	CcSEcCtD
Labetalol—Hypertension—Paclitaxel—ovarian cancer	0.0017	0.00173	CcSEcCtD
Labetalol—Alopecia—Docetaxel—ovarian cancer	0.00169	0.00173	CcSEcCtD
Labetalol—Pruritus—Vinorelbine—ovarian cancer	0.00169	0.00172	CcSEcCtD
Labetalol—Mental disorder—Docetaxel—ovarian cancer	0.00168	0.00171	CcSEcCtD
Labetalol—Erythema—Docetaxel—ovarian cancer	0.00167	0.0017	CcSEcCtD
Labetalol—Nausea—Topotecan—ovarian cancer	0.00166	0.00169	CcSEcCtD
Labetalol—Discomfort—Paclitaxel—ovarian cancer	0.00166	0.00169	CcSEcCtD
Labetalol—Mood swings—Doxorubicin—ovarian cancer	0.00164	0.00167	CcSEcCtD
Labetalol—Diarrhoea—Vinorelbine—ovarian cancer	0.00163	0.00167	CcSEcCtD
Labetalol—Nausea—Melphalan—ovarian cancer	0.00162	0.00166	CcSEcCtD
Labetalol—Confusional state—Paclitaxel—ovarian cancer	0.00162	0.00165	CcSEcCtD
Labetalol—Oedema—Paclitaxel—ovarian cancer	0.00161	0.00164	CcSEcCtD
Labetalol—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00161	0.00164	CcSEcCtD
Labetalol—Muscle spasms—Docetaxel—ovarian cancer	0.0016	0.00164	CcSEcCtD
Labetalol—Liver function test abnormal—Doxorubicin—ovarian cancer	0.0016	0.00163	CcSEcCtD
Labetalol—Shock—Paclitaxel—ovarian cancer	0.00158	0.00161	CcSEcCtD
Labetalol—Dizziness—Vinorelbine—ovarian cancer	0.00158	0.00161	CcSEcCtD
Labetalol—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00158	0.00161	CcSEcCtD
Labetalol—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00158	0.00161	CcSEcCtD
Labetalol—Angina pectoris—Epirubicin—ovarian cancer	0.00157	0.00161	CcSEcCtD
Labetalol—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00155	0.00159	CcSEcCtD
Labetalol—Vomiting—Vinorelbine—ovarian cancer	0.00152	0.00155	CcSEcCtD
Labetalol—Dysuria—Epirubicin—ovarian cancer	0.00151	0.00154	CcSEcCtD
Labetalol—Rash—Vinorelbine—ovarian cancer	0.00151	0.00154	CcSEcCtD
Labetalol—Dermatitis—Vinorelbine—ovarian cancer	0.0015	0.00154	CcSEcCtD
Labetalol—Hypotension—Paclitaxel—ovarian cancer	0.0015	0.00153	CcSEcCtD
Labetalol—Headache—Vinorelbine—ovarian cancer	0.0015	0.00153	CcSEcCtD
Labetalol—Syncope—Docetaxel—ovarian cancer	0.0015	0.00153	CcSEcCtD
Labetalol—Palpitations—Docetaxel—ovarian cancer	0.00147	0.0015	CcSEcCtD
Labetalol—Loss of consciousness—Docetaxel—ovarian cancer	0.00147	0.0015	CcSEcCtD
Labetalol—Angina pectoris—Doxorubicin—ovarian cancer	0.00146	0.00149	CcSEcCtD
Labetalol—Paraesthesia—Paclitaxel—ovarian cancer	0.00144	0.00147	CcSEcCtD
Labetalol—Hypertension—Docetaxel—ovarian cancer	0.00144	0.00147	CcSEcCtD
Labetalol—Drowsiness—Epirubicin—ovarian cancer	0.00144	0.00147	CcSEcCtD
Labetalol—Dyspnoea—Paclitaxel—ovarian cancer	0.00143	0.00146	CcSEcCtD
Labetalol—Somnolence—Paclitaxel—ovarian cancer	0.00143	0.00146	CcSEcCtD
Labetalol—Nausea—Vinorelbine—ovarian cancer	0.00142	0.00145	CcSEcCtD
Labetalol—Dyspepsia—Paclitaxel—ovarian cancer	0.00141	0.00144	CcSEcCtD
Labetalol—Jaundice—Epirubicin—ovarian cancer	0.0014	0.00143	CcSEcCtD
Labetalol—Dysuria—Doxorubicin—ovarian cancer	0.0014	0.00143	CcSEcCtD
Labetalol—Fatigue—Paclitaxel—ovarian cancer	0.00139	0.00141	CcSEcCtD
Labetalol—Sweating—Epirubicin—ovarian cancer	0.00138	0.00141	CcSEcCtD
Labetalol—Constipation—Paclitaxel—ovarian cancer	0.00137	0.0014	CcSEcCtD
Labetalol—Pain—Paclitaxel—ovarian cancer	0.00137	0.0014	CcSEcCtD
Labetalol—Confusional state—Docetaxel—ovarian cancer	0.00137	0.0014	CcSEcCtD
Labetalol—Oedema—Docetaxel—ovarian cancer	0.00136	0.00139	CcSEcCtD
Labetalol—Anaphylactic shock—Docetaxel—ovarian cancer	0.00136	0.00139	CcSEcCtD
Labetalol—Epistaxis—Epirubicin—ovarian cancer	0.00136	0.00139	CcSEcCtD
Labetalol—Propafenone—ABCB1—ovarian cancer	0.00135	0.0674	CrCbGaD
Labetalol—Agranulocytosis—Epirubicin—ovarian cancer	0.00134	0.00137	CcSEcCtD
Labetalol—Shock—Docetaxel—ovarian cancer	0.00134	0.00137	CcSEcCtD
Labetalol—Drowsiness—Doxorubicin—ovarian cancer	0.00133	0.00136	CcSEcCtD
Labetalol—Feeling abnormal—Paclitaxel—ovarian cancer	0.00132	0.00135	CcSEcCtD
Labetalol—Bradycardia—Epirubicin—ovarian cancer	0.00132	0.00134	CcSEcCtD
Labetalol—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00131	0.00134	CcSEcCtD
Labetalol—Jaundice—Doxorubicin—ovarian cancer	0.0013	0.00133	CcSEcCtD
Labetalol—Hepatitis—Epirubicin—ovarian cancer	0.00129	0.00132	CcSEcCtD
Labetalol—Hypoaesthesia—Epirubicin—ovarian cancer	0.00129	0.00131	CcSEcCtD
Labetalol—Sweating—Doxorubicin—ovarian cancer	0.00128	0.0013	CcSEcCtD
Labetalol—Urticaria—Paclitaxel—ovarian cancer	0.00128	0.0013	CcSEcCtD
Labetalol—Oedema peripheral—Epirubicin—ovarian cancer	0.00127	0.0013	CcSEcCtD
Labetalol—Hypotension—Docetaxel—ovarian cancer	0.00127	0.0013	CcSEcCtD
Labetalol—Body temperature increased—Paclitaxel—ovarian cancer	0.00127	0.0013	CcSEcCtD
Labetalol—Abdominal pain—Paclitaxel—ovarian cancer	0.00127	0.0013	CcSEcCtD
Labetalol—Epistaxis—Doxorubicin—ovarian cancer	0.00126	0.00128	CcSEcCtD
Labetalol—Visual impairment—Epirubicin—ovarian cancer	0.00125	0.00127	CcSEcCtD
Labetalol—Agranulocytosis—Doxorubicin—ovarian cancer	0.00124	0.00127	CcSEcCtD
Labetalol—Paraesthesia—Docetaxel—ovarian cancer	0.00122	0.00125	CcSEcCtD
Labetalol—Bradycardia—Doxorubicin—ovarian cancer	0.00122	0.00124	CcSEcCtD
Labetalol—Dyspnoea—Docetaxel—ovarian cancer	0.00121	0.00124	CcSEcCtD
Labetalol—Somnolence—Docetaxel—ovarian cancer	0.00121	0.00124	CcSEcCtD
Labetalol—Flushing—Epirubicin—ovarian cancer	0.0012	0.00122	CcSEcCtD
Labetalol—Dyspepsia—Docetaxel—ovarian cancer	0.0012	0.00122	CcSEcCtD
Labetalol—Hepatitis—Doxorubicin—ovarian cancer	0.0012	0.00122	CcSEcCtD
Labetalol—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00119	0.00121	CcSEcCtD
Labetalol—Hypersensitivity—Paclitaxel—ovarian cancer	0.00118	0.00121	CcSEcCtD
Labetalol—Oedema peripheral—Doxorubicin—ovarian cancer	0.00118	0.0012	CcSEcCtD
Labetalol—Fatigue—Docetaxel—ovarian cancer	0.00117	0.0012	CcSEcCtD
Labetalol—Constipation—Docetaxel—ovarian cancer	0.00116	0.00119	CcSEcCtD
Labetalol—Pain—Docetaxel—ovarian cancer	0.00116	0.00119	CcSEcCtD
Labetalol—Visual impairment—Doxorubicin—ovarian cancer	0.00115	0.00118	CcSEcCtD
Labetalol—Asthenia—Paclitaxel—ovarian cancer	0.00115	0.00118	CcSEcCtD
Labetalol—Alopecia—Epirubicin—ovarian cancer	0.00114	0.00117	CcSEcCtD
Labetalol—Pruritus—Paclitaxel—ovarian cancer	0.00114	0.00116	CcSEcCtD
Labetalol—Mental disorder—Epirubicin—ovarian cancer	0.00113	0.00116	CcSEcCtD
Labetalol—Erythema—Epirubicin—ovarian cancer	0.00113	0.00115	CcSEcCtD
Labetalol—Feeling abnormal—Docetaxel—ovarian cancer	0.00112	0.00115	CcSEcCtD
Labetalol—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00111	0.00114	CcSEcCtD
Labetalol—Flushing—Doxorubicin—ovarian cancer	0.00111	0.00113	CcSEcCtD
Labetalol—Diarrhoea—Paclitaxel—ovarian cancer	0.0011	0.00112	CcSEcCtD
Labetalol—Muscle spasms—Epirubicin—ovarian cancer	0.00108	0.0011	CcSEcCtD
Labetalol—Abdominal pain—Docetaxel—ovarian cancer	0.00108	0.0011	CcSEcCtD
Labetalol—Body temperature increased—Docetaxel—ovarian cancer	0.00108	0.0011	CcSEcCtD
Labetalol—Dizziness—Paclitaxel—ovarian cancer	0.00106	0.00108	CcSEcCtD
Labetalol—Vision blurred—Epirubicin—ovarian cancer	0.00106	0.00108	CcSEcCtD
Labetalol—Alopecia—Doxorubicin—ovarian cancer	0.00106	0.00108	CcSEcCtD
Labetalol—Mental disorder—Doxorubicin—ovarian cancer	0.00105	0.00107	CcSEcCtD
Labetalol—Ill-defined disorder—Epirubicin—ovarian cancer	0.00104	0.00107	CcSEcCtD
Labetalol—Erythema—Doxorubicin—ovarian cancer	0.00104	0.00106	CcSEcCtD
Labetalol—Vomiting—Paclitaxel—ovarian cancer	0.00102	0.00104	CcSEcCtD
Labetalol—Malaise—Epirubicin—ovarian cancer	0.00102	0.00104	CcSEcCtD
Labetalol—Rash—Paclitaxel—ovarian cancer	0.00101	0.00103	CcSEcCtD
Labetalol—Dermatitis—Paclitaxel—ovarian cancer	0.00101	0.00103	CcSEcCtD
Labetalol—Vertigo—Epirubicin—ovarian cancer	0.00101	0.00103	CcSEcCtD
Labetalol—Syncope—Epirubicin—ovarian cancer	0.00101	0.00103	CcSEcCtD
Labetalol—Headache—Paclitaxel—ovarian cancer	0.00101	0.00103	CcSEcCtD
Labetalol—Hypersensitivity—Docetaxel—ovarian cancer	0.001	0.00102	CcSEcCtD
Labetalol—Muscle spasms—Doxorubicin—ovarian cancer	0.001	0.00102	CcSEcCtD
Labetalol—Palpitations—Epirubicin—ovarian cancer	0.000995	0.00101	CcSEcCtD
Labetalol—Loss of consciousness—Epirubicin—ovarian cancer	0.000989	0.00101	CcSEcCtD
Labetalol—Vision blurred—Doxorubicin—ovarian cancer	0.000982	0.001	CcSEcCtD
Labetalol—Asthenia—Docetaxel—ovarian cancer	0.000977	0.000997	CcSEcCtD
Labetalol—Hypertension—Epirubicin—ovarian cancer	0.000972	0.000992	CcSEcCtD
Labetalol—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000966	0.000986	CcSEcCtD
Labetalol—Pruritus—Docetaxel—ovarian cancer	0.000964	0.000983	CcSEcCtD
Labetalol—Nausea—Paclitaxel—ovarian cancer	0.000954	0.000974	CcSEcCtD
Labetalol—Discomfort—Epirubicin—ovarian cancer	0.000947	0.000966	CcSEcCtD
Labetalol—Malaise—Doxorubicin—ovarian cancer	0.000939	0.000958	CcSEcCtD
Labetalol—Vertigo—Doxorubicin—ovarian cancer	0.000936	0.000955	CcSEcCtD
Labetalol—Syncope—Doxorubicin—ovarian cancer	0.000934	0.000953	CcSEcCtD
Labetalol—Diarrhoea—Docetaxel—ovarian cancer	0.000932	0.000951	CcSEcCtD
Labetalol—Confusional state—Epirubicin—ovarian cancer	0.000926	0.000945	CcSEcCtD
Labetalol—Palpitations—Doxorubicin—ovarian cancer	0.00092	0.000939	CcSEcCtD
Labetalol—Anaphylactic shock—Epirubicin—ovarian cancer	0.000919	0.000937	CcSEcCtD
Labetalol—Oedema—Epirubicin—ovarian cancer	0.000919	0.000937	CcSEcCtD
Labetalol—Loss of consciousness—Doxorubicin—ovarian cancer	0.000915	0.000934	CcSEcCtD
Labetalol—Shock—Epirubicin—ovarian cancer	0.000904	0.000922	CcSEcCtD
Labetalol—Dizziness—Docetaxel—ovarian cancer	0.000901	0.000919	CcSEcCtD
Labetalol—Hypertension—Doxorubicin—ovarian cancer	0.000899	0.000918	CcSEcCtD
Labetalol—Hyperhidrosis—Epirubicin—ovarian cancer	0.000888	0.000906	CcSEcCtD
Labetalol—Discomfort—Doxorubicin—ovarian cancer	0.000876	0.000894	CcSEcCtD
Labetalol—Vomiting—Docetaxel—ovarian cancer	0.000866	0.000884	CcSEcCtD
Labetalol—Rash—Docetaxel—ovarian cancer	0.000859	0.000876	CcSEcCtD
Labetalol—Hypotension—Epirubicin—ovarian cancer	0.000858	0.000876	CcSEcCtD
Labetalol—Dermatitis—Docetaxel—ovarian cancer	0.000858	0.000875	CcSEcCtD
Labetalol—Confusional state—Doxorubicin—ovarian cancer	0.000857	0.000875	CcSEcCtD
Labetalol—Headache—Docetaxel—ovarian cancer	0.000853	0.000871	CcSEcCtD
Labetalol—Oedema—Doxorubicin—ovarian cancer	0.00085	0.000867	CcSEcCtD
Labetalol—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00085	0.000867	CcSEcCtD
Labetalol—Shock—Doxorubicin—ovarian cancer	0.000836	0.000853	CcSEcCtD
Labetalol—Paraesthesia—Epirubicin—ovarian cancer	0.000825	0.000842	CcSEcCtD
Labetalol—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000822	0.000838	CcSEcCtD
Labetalol—Dyspnoea—Epirubicin—ovarian cancer	0.000819	0.000836	CcSEcCtD
Labetalol—Somnolence—Epirubicin—ovarian cancer	0.000817	0.000833	CcSEcCtD
Labetalol—Nausea—Docetaxel—ovarian cancer	0.000809	0.000825	CcSEcCtD
Labetalol—Dyspepsia—Epirubicin—ovarian cancer	0.000809	0.000825	CcSEcCtD
Labetalol—Hypotension—Doxorubicin—ovarian cancer	0.000794	0.00081	CcSEcCtD
Labetalol—Fatigue—Epirubicin—ovarian cancer	0.000792	0.000808	CcSEcCtD
Labetalol—Pain—Epirubicin—ovarian cancer	0.000786	0.000802	CcSEcCtD
Labetalol—Constipation—Epirubicin—ovarian cancer	0.000786	0.000802	CcSEcCtD
Labetalol—Paraesthesia—Doxorubicin—ovarian cancer	0.000763	0.000779	CcSEcCtD
Labetalol—Dyspnoea—Doxorubicin—ovarian cancer	0.000758	0.000773	CcSEcCtD
Labetalol—Feeling abnormal—Epirubicin—ovarian cancer	0.000757	0.000772	CcSEcCtD
Labetalol—Somnolence—Doxorubicin—ovarian cancer	0.000756	0.000771	CcSEcCtD
Labetalol—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000751	0.000766	CcSEcCtD
Labetalol—Dyspepsia—Doxorubicin—ovarian cancer	0.000748	0.000763	CcSEcCtD
Labetalol—Fatigue—Doxorubicin—ovarian cancer	0.000733	0.000748	CcSEcCtD
Labetalol—Urticaria—Epirubicin—ovarian cancer	0.00073	0.000745	CcSEcCtD
Labetalol—Constipation—Doxorubicin—ovarian cancer	0.000727	0.000742	CcSEcCtD
Labetalol—Pain—Doxorubicin—ovarian cancer	0.000727	0.000742	CcSEcCtD
Labetalol—Body temperature increased—Epirubicin—ovarian cancer	0.000726	0.000741	CcSEcCtD
Labetalol—Abdominal pain—Epirubicin—ovarian cancer	0.000726	0.000741	CcSEcCtD
Labetalol—Feeling abnormal—Doxorubicin—ovarian cancer	0.0007	0.000715	CcSEcCtD
Labetalol—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000695	0.000709	CcSEcCtD
Labetalol—Hypersensitivity—Epirubicin—ovarian cancer	0.000677	0.000691	CcSEcCtD
Labetalol—Urticaria—Doxorubicin—ovarian cancer	0.000675	0.000689	CcSEcCtD
Labetalol—Abdominal pain—Doxorubicin—ovarian cancer	0.000672	0.000686	CcSEcCtD
Labetalol—Body temperature increased—Doxorubicin—ovarian cancer	0.000672	0.000686	CcSEcCtD
Labetalol—Asthenia—Epirubicin—ovarian cancer	0.000659	0.000673	CcSEcCtD
Labetalol—Pruritus—Epirubicin—ovarian cancer	0.00065	0.000663	CcSEcCtD
Labetalol—Diarrhoea—Epirubicin—ovarian cancer	0.000629	0.000641	CcSEcCtD
Labetalol—Hypersensitivity—Doxorubicin—ovarian cancer	0.000626	0.000639	CcSEcCtD
Labetalol—Asthenia—Doxorubicin—ovarian cancer	0.00061	0.000622	CcSEcCtD
Labetalol—Dizziness—Epirubicin—ovarian cancer	0.000607	0.00062	CcSEcCtD
Labetalol—Pruritus—Doxorubicin—ovarian cancer	0.000601	0.000614	CcSEcCtD
Labetalol—Vomiting—Epirubicin—ovarian cancer	0.000584	0.000596	CcSEcCtD
Labetalol—Diarrhoea—Doxorubicin—ovarian cancer	0.000582	0.000593	CcSEcCtD
Labetalol—Rash—Epirubicin—ovarian cancer	0.000579	0.000591	CcSEcCtD
Labetalol—Dermatitis—Epirubicin—ovarian cancer	0.000579	0.00059	CcSEcCtD
Labetalol—Headache—Epirubicin—ovarian cancer	0.000575	0.000587	CcSEcCtD
Labetalol—Dizziness—Doxorubicin—ovarian cancer	0.000562	0.000574	CcSEcCtD
Labetalol—Nausea—Epirubicin—ovarian cancer	0.000546	0.000557	CcSEcCtD
Labetalol—Vomiting—Doxorubicin—ovarian cancer	0.00054	0.000551	CcSEcCtD
Labetalol—Rash—Doxorubicin—ovarian cancer	0.000536	0.000547	CcSEcCtD
Labetalol—Dermatitis—Doxorubicin—ovarian cancer	0.000535	0.000546	CcSEcCtD
Labetalol—Headache—Doxorubicin—ovarian cancer	0.000532	0.000543	CcSEcCtD
Labetalol—Nausea—Doxorubicin—ovarian cancer	0.000505	0.000515	CcSEcCtD
